Patent Application
App. No. 13/244,582
CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY
Loading inventors, assignments & file history…
Abstract
The invention provides cell-permeable peptides that bind to JNK protein and inhibit JNK-mediated effects in JNK-expressing cells.
Claims (5)
1 .- 37 . (canceled)
38 . A D-enantiomeric peptide comprising the amino acid sequence of SEQ ID NO: 8, wherein said peptide facilitates transport across a biological membrane.
39 . A transport protein comprising a D-enantiomeric peptide, said D-enantiomeric peptide consisting of the amino acid sequence of SEQ ID NO: 8.
40 . A polypeptide comprising the peptide of claim 38 and a protein covalently bound to said peptide.
41 . A transport protein consisting of a D-enantiomeric peptide, said D-enantiomeric peptide consisting of the amino acid sequence of SEQ ID NO: 8.
Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 30, 2013
From: BONNY, CHRISTOPHE
To: UNIVERSITE DE LAUSANNE
Reel/Frame 031857/0190 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 30, 2013
From: UNIVERSITY OF LAUSANNE
To: XIGEN S.A.
Reel/Frame 031857/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 4, 2013
From: XIGEN S.A.
To: XIGEN INFLAMMATION LTD.
Reel/Frame 031534/0920 →